U.S. Stock Alert | GlucoTrack (GCTK.US) Surges Over 123% Following Agreement to Sell Up to $20 Million in Common Stock

Stock News
2025/09/12

On Friday, GlucoTrack, Inc. (GCTK.US) soared over 123%, trading at $10.91. The surge came after GlucoTrack, Inc. announced on September 11, 2025, that it has entered into an agreement with Sixth District Capital to sell up to $20 million in common stock. GlucoTrack, Inc. is primarily engaged in developing implantable continuous glucose monitoring devices that directly measure blood glucose levels, eliminating lag time and providing solutions for diabetes patients.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10